Rick is the Chief Executive Officer of Apertus Pharmaceuticals, a St. Louis based contract manufacturing company, and Partner with Cultivation Capital Life Sciences. Rick currently serves on the board of two of Euclises, Molecular Sensing, ApoCell (Houston TX) and Firefly Biosystems (Boston). Rick has over 30 years’ experience in the life sciences industry including business management and new business/technology development. He has held executive leadership positions in multinational corporations as well as early stage ventures. Before joining Apertus and Cultivation Capital, Rick was Vice President of the Drug Discovery & Development business unit at Millipore. Rick was formerly the President of LINCO Research, which was acquired by Millipore in 2007. He started his biotechnology career at Monsanto, where he held several technology and business management positions of increasing responsibility. Rick received his PhD from the University of Illinois and his executive MBA from Washington University in St. Louis. Rick was an American Cancer Society post-doctoral fellow at the University of Wisconsin. He obtained his BS in chemistry from Central College of Iowa.